Michael Hegener, PharmD, BCACP

home / authors / michael-hegener-pharmd-bcacp

Articles

Q&A: Support, Reimbursement Key For Expanded Pharmacy Services | PQA 2025

Q&A: Support, Reimbursement Key For Expanded Pharmacy Services | PQA 2025

Killian Meara;Michael Hegener, PharmD, BCACP
May 29th 2025

Michael Hegener, PharmD, BCACP, discusses how workforce development can best address the evolving knowledge, skills, and abilities needed in community pharmacy practice.

Q&A: Workflow Changes Needed as Pharmacies Take on Clinical Roles | PQA 2025

Q&A: Workflow Changes Needed as Pharmacies Take on Clinical Roles | PQA 2025

Killian Meara;Michael Hegener, PharmD, BCACP
May 27th 2025

Michael Hegener, PharmD, BCACP, discusses what workflow changes are essential to support the expansion of patient care services in community pharmacies.

Confidence, Collaboration Key For Advancing Community Pharmacy Services | PQA 2025

Confidence, Collaboration Key For Advancing Community Pharmacy Services | PQA 2025

Killian Meara;Michael Hegener, PharmD, BCACP
May 27th 2025

Michael Hegener, PharmD, BCACP, discusses how collaboration with health plans and pharmacy employers can enhance the implementation of practice redesign initiatives.

The Future of Patient Care Services in Community Pharmacy | PQA 2025

The Future of Patient Care Services in Community Pharmacy | PQA 2025

Killian Meara;Michael Hegener, PharmD, BCACP
May 21st 2025

A conversation with Michael Hegener, PharmD, BCACP, associate professor of Pharmacy at the University of Cincinnati, at PQA 2025.

Latest Updated Articles

In This Issue: Total Pharmacy August 2024
Published: August 6th 2024 | Updated: August 20th 2024
In This Issue: Total Pharmacy August 2024
SGLT2i, GLP-1RA Combination Therapy Offers Robust Protection Against Cardiovascular, Kidney Disease
Published: July 8th 2024 | Updated: July 10th 2024
SGLT2i, GLP-1RA Combination Therapy Offers Robust Protection Against Cardiovascular, Kidney Disease
Lilly’s Once-Weekly Insulin Efsitora Offers Comparable Results to Daily Insulin in T1D, T2D
Published: September 12th 2024 | Updated: July 6th 2025
Lilly’s Once-Weekly Insulin Efsitora Offers Comparable Results to Daily Insulin in T1D, T2D
Education is Crucial to Prevent Hypoglycemia in Patients with Diabetes
Published: December 19th 2024 | Updated: July 6th 2025
Education is Crucial to Prevent Hypoglycemia in Patients with Diabetes
Inhaled Insulin for Pediatric Patients Shows Positive Results in Phase 3 Trial
Published: December 18th 2024 | Updated: July 6th 2025
Inhaled Insulin for Pediatric Patients Shows Positive Results in Phase 3 Trial
Assessing Improvements to Reduce Insulin-Related Hypoglycemic Events | ASHP Midyear
Published: December 10th 2024 | Updated: July 6th 2025
Assessing Improvements to Reduce Insulin-Related Hypoglycemic Events | ASHP Midyear
© 2025 MJH Life Sciences

All rights reserved.